II. Definitions
- Cardiac Rehabilitation
- Supervised program to improve CV health following MI, Angioplasty or heart surgery
- Program includes Exercise, education and emotional counseling
III. Background
- Cardiac Rehabilitation has great efficacy and cost effectiveness as a secondary prevention tool
- Cardiac Rehabilitation is under-utilized by Medicare-eligible indications (only 20-30% participation)
- Cardiac Rehabilitation post-hospitalization referral rates are 40% of those eligible
- Lower referral rates in women, as well as non-white patients
IV. Indications
-
Medicare reimbursed indications (3 sesssions per week for 3 months)
- Following acute Myocardial Infarction (STEMI or non-STEMI) in the last 12 months
- Status-post Coronary Artery Bypass Graft (CABG)
- Status-post Percutaneous Coronary Intervention (PCI)
- Stable Angina Pectoris
- Status-post Vascular Surgery
- Status-post Heart Transplantation
- Status-post Heart Valve Repair or Replacement
- Recent CVA (women only)
- Other indications
- Stable Congestive Heart Failure with reduced left-ventricular ejection fraction
- Symptomatic Peripheral Arterial Disease
- Status-post Ventricular Assist Device placement
- Pacemaker or Implantable Cardioverter-Defibrillator
V. Protocol: Cardiac Rehabilitation Phases
-
General
- Standard programs
- Intensive programs (limited availability)
- Intensive programs may include up to 72 sessions over up to 18 weeks
- Medicare approved programs
- Dean Ornish Program for Reversing Heart Disease
- Pritikin Intensive Cardiac Rehab Program
- Benson-Henry Institute Cardiac Wellness Program
- Phase I Cardiac Rehabilitation (during hospitalization for acute event or procedure)
- Supervised, structured early Physical Activity
- Patient Education
- Risk stratification (low level, graded, Exercise tolerance testing)
- Phase II Cardiac Rehabilitation (Early Outpatient)
- Start within 1-2 weeks of sentinel cardiac event (unless delayed for medical/surgical reasons)
- Supervised Physical Activity program
- Reassess symptom-limited Exercise tolerance
- Custom tailored Exercise Prescription for 30 minutes daily and 5 days weekly
- Overall plan is updated at a minimum every 30 days
- Monitoring of Blood Pressure, pulse, cardiac rhythm
- Maintain Blood Pressure <140/90 mmHg
- Nutrition counseling
- May involve education on cooking and grocery shopping
- Diabetes Mellitus Type II control with Hemoglobin A1C <8%
- LDL Cholesterol <100 mg/dl (preferable <70 mg/dl)
- Body Mass Index reduction towards goal of <27 kg/m2 (ideally <25 kg/m2)
- Cardiac Risk Factor modification
- Tobacco Cessation (and other Substance Use Disorder Management)
- Reassess cardiac symptoms at rest and with activity
- Psychosocial support to screen for and manage Major Depression, cognitive disorders
- Gait assessment and Fall Prevention
- Phase III Cardiac Rehabilitation Maintenance (Late Outpatient)
- Supervised, extended outpatient program
- Maintain and reinforce phase I and II management
- Reinforce medication use, Patient Education
- Phase IV Community Based Maintenance Programs
- Reinforce independent maintenance of long-term, heart healthy lifestyle changes
- Self-directed Exercise (aerobic fitness, Strength Training, flexibility, balance and group Exercise)
- Continuing education, peer support, and as needed, qualified Exercise instructors
- Continued health monitoring (self monitoring as well as regular clinic visits)
VI. Protocol: Activity restrictions following acute Myocardial Infarction
- Gradually increase activity over 6-8 weeks following MI
- Return to work by 8 weeks after MI
- Activity program may start by 3-4 weeks after MI
- Sexual activity restarted at 4-6 weeks after MI
- See Sexual Intercourse after Myocardial Infarction
VII. Protocol: Other Measures
- Influenza Vaccine each year
VIII. Efficacy
- Reduced Angina, Dyspnea, and Fatigue
- Reduced Major Depression after acute coronary event
- Exercise performance improved
- Activities of Daily Living (ADL) performance improved
- Quality of life improved
- Decreased re-hospitalization rate
- Decreased work absence
- Reduced age-adjusted cardiovascular mortality by 50%
- References
- Bondestam (1995) Am J Cardiol 75:767-71 +PMID: 7717276 [PubMed]
- Lakhani (2023) Am J Cardiol 192: 60-66 +PMID: 36736014 [PubMed]
- Milani (2007) Am J Med 120(9): 799-806 +PMID: 17765050 [PubMed]
- Dibben (2021) Cochrane Database Syst Rev (11): CD01800 +PMID: 34741536 [PubMed]
- Dibben (2018) Heart 104(17): 1394-402 +PMID: 29654095 [PubMed]